v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses    
Research and development $ 10,645,222 $ 11,471,693
General and administrative 4,682,495 4,005,642
Amortization of intangible asset 7,317 7,317
Total operating expenses 15,335,034 15,484,652
Loss from operations (15,335,034) (15,484,652)
Other income (expense)    
Interest income 1,360,404 438,520
Other income, net 513,735 0
Net loss $ (13,460,895) $ (15,046,132)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.21) $ (0.42)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.21) $ (0.42)
Weighted-average common shares outstanding, basic (in shares) 64,658,809 35,529,652
Weighted-average common shares outstanding, diluted (in shares) 64,658,809 35,529,652
Other comprehensive loss:    
Unrealized loss from marketable securities $ (322,337) $ 0
Comprehensive Loss $ (13,783,232) $ (15,046,132)